DDOG

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $266.34 to $267.33. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $270.4 to $270.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $257.18 to $257.23. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $268.37 to $269.34. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $269.39 to $269.92. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $265.28 to $266.06. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $255.24 to $256.22. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $264.24 to $264.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $263.15 to $264.12. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $267.34 to $268.31. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $253.39 to $254.38. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $257.42 to $258.39. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $251.29 to $252.28. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $256.42 to $257.41. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $254.39 to $255.38. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $255.41 to $256.39. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $258.42 to $259.41. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $260.46 to $261.39. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Option is fully vested and exercisable.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $252.31 to $253.29. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $259.43 to $260.33. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $259.14 to $260.13. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $261.14 to $262.07. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $258.13 to $259.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $263.27 to $264.14. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $265.36 to $266.20. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $264.28 to $265.27. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $262.18 to $263.06. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $260.14 to $261.13. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

This Class A Common Stock was issued to the Reporting Person pursuant to the Issuers non-employee director compensation policy, based on his election to receive equity in lieu of cash.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $215.60 to $216.45. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $216.60 to $217.56. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.